CDCA2 and cancer: The results showed that CDCA2 had a high predictive performance (AUC > 0.9) for 20 cancer types, including BLCA, BRCA, CESC, CHOL, COAD, ESCA, GBM, KIRC, LAML, LGG, LIHC, LUAD, LUSC, OV, OSCC, PAAD, READ, STAD, UCEC, and UCS (Fig 4).